The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis

Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):50-2. doi: 10.1016/s0035-9203(97)90393-x.

Abstract

In Papua New Guinea visual loss is a frequent sequal to Cryptococcus neoformans var. gattii meningitis in immunocompetent patients. We have previously postulated that visual loss may occur as a result of the immunological response to infection around the optic nerve. This retrospective study set out to explore the effect of corticosteroids on visual outcome. Sixteen patients received varying doses of corticosteroid (mainly 100-250 mg of hydrocortisone daily for the prevention of febrile reactions to amphotericin) and 10 received anticryptococcal therapy alone. Visual deterioration occurred less frequently in those treated with corticosteroids (2/16 [12.5%] vs. 7/10 [70%], P = 0.007), blindness was less frequent (1/16 [5.3%] vs. 5/10 [50%], P = 0.018), and in 3 patients vision improved. Corticosteroids may have a role in preventing or halting visual loss in C. neoformans var. gattii meningitis in immunocompetent patients.

MeSH terms

  • Adolescent
  • Adult
  • Amphotericin B / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use*
  • Antifungal Agents / therapeutic use
  • Blindness / prevention & control
  • Child
  • Cryptococcosis / complications
  • Cryptococcosis / drug therapy*
  • Dexamethasone / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone / therapeutic use
  • Male
  • Meningitis, Fungal / drug therapy*
  • Prednisolone / therapeutic use
  • Pseudotumor Cerebri / complications
  • Pseudotumor Cerebri / drug therapy
  • Retrospective Studies
  • Vision Disorders / complications
  • Vision Disorders / prevention & control*

Substances

  • Anti-Inflammatory Agents
  • Antifungal Agents
  • Dexamethasone
  • Amphotericin B
  • Prednisolone
  • Hydrocortisone